7 recruiting. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 7 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of FT1 in Patients With Short Bowel Syndrome FT1, Placebo - Short Bowel Syndrome, SBS | Phase 2 | Recruiting | Chongqing Peg-Bio Biopharm Co., Ltd. | 8 | 2026-08-30 | 2026-07-15 |
| Study of DONQ52 in Active Celiac Disease Placebo DONQ52, Simulated Inadvertent Gluten Exposure (SIGE) capsule, DONQ52 - Celiac Disease | Phase 2 | Recruiting | Chugai Pharmaceutical | 92 | 2025-12-16 | 2026-08-14 |
| Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA ELGN-2112, Placebo - Intestinal Malabsorption | Phase 2 | Recruiting | Elgan Pharma Ltd. | 60 | 2025-10-28 | 2026-04-09 |
| Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease FB102, Placebo - Celiac Disease | Phase 2 | Recruiting | Forte Biosciences, Inc. | 100 | 2025-08-04 | 2025-11-18 |
| Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes | Phase 2 | Recruiting | Napo Therapeutics, S.p.A. | 18 | 2025-05-29 | 2026-06-09 |
| Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease ZED1227 + SIGE, Placebo - Celiac Disease | Phase 2 | Recruiting | Dr. Falk Pharma GmbH | 356 | 2024-06-10 | 2026-04-02 |
| Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects HM15912 Active, Placebo - Short Bowel Syndrome | Phase 2 | Recruiting | Hanmi Pharmaceutical Company Limited | 18 | 2022-03-03 | 2026-08-12 |
Celiac Disease (3) · Short Bowel Syndrome (3) · Gastrointestinal Diseases (1) · Postoperative Complications (1)
Digestive System Diseases (7) · Intestinal Diseases (7) · Gastrointestinal Diseases (6) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Postoperative Complications (2)
Capsules (1) · Solutions (1) · ZED1227 (1)
Chongqing Peg-Bio Biopharm Co., Ltd. (1) · Chugai Pharmaceutical (1) · Dr. Falk Pharma GmbH (1) · Elgan Pharma Ltd. (1) · Forte Biosciences, Inc. (1) · Hanmi Pharmaceutical Company Limited (1) · Napo Therapeutics, S.p.A. (1)
Germany (3) · Australia (2) · United States (2) · Belgium (1) · China (1) · Denmark (1) · France (1) · Israel (1) · Italy (1) · New Zealand (1) · Poland (1) · South Korea (1) · United Kingdom (1)
Miki Olshansky (1)
2023 (1)